Cover Page - USD ($) $ in Millions |
12 Months Ended |
|
|
Dec. 31, 2022 |
Jan. 31, 2023 |
Jun. 30, 2022 |
| Cover [Abstract] |
|
|
|
| Document Type |
10-K
|
|
|
| Document Annual Report |
true
|
|
|
| Document Period End Date |
Dec. 31, 2022
|
|
|
| Current Fiscal Year End Date |
--12-31
|
|
|
| Document Transition Report |
false
|
|
|
| Entity File Number |
001-38586
|
|
|
| Entity Registrant Name |
RUBIUS THERAPEUTICS, INC.
|
|
|
| Entity Incorporation, State or Country Code |
DE
|
|
|
| Entity Tax Identification Number |
46-2688109
|
|
|
| Entity Address, Address Line One |
c/o Verdolino & Lowey, P.C.
|
|
|
| Entity Address, Address Line Two |
124 Washington Street,
|
|
|
| Entity Address, Address Line Three |
Suite 101
|
|
|
| Entity Address, City or Town |
Foxborough,
|
|
|
| Entity Address, State or Province |
MA
|
|
|
| Entity Address, Postal Zip Code |
02035
|
|
|
| City Area Code |
(508)
|
|
|
| Local Phone Number |
543-1720
|
|
|
| Title of 12(b) Security |
Common Stock, par value $0.001 per share
|
|
|
| Trading Symbol |
RUBY
|
|
|
| Security Exchange Name |
NASDAQ
|
|
|
| Entity Well-known Seasoned Issuer |
No
|
|
|
| Entity Voluntary Filers |
No
|
|
|
| Entity Current Reporting Status |
Yes
|
|
|
| Entity Interactive Data Current |
Yes
|
|
|
| Entity Filer Category |
Non-accelerated Filer
|
|
|
| Entity Small Business |
true
|
|
|
| Entity Emerging Growth Company |
false
|
|
|
| Entity Shell Company |
false
|
|
|
| Entity Public Float |
|
|
$ 28.4
|
| Entity Common Stock, Shares Outstanding |
|
90,397,732
|
|
| Document Fiscal Year Focus |
2022
|
|
|
| Document Fiscal Period Focus |
FY
|
|
|
| Entity Central Index Key |
0001709401
|
|
|
| Amendment Flag |
false
|
|
|